Xenon-VR Announces Name Change to Xenon Ophthalmics and Patents Granted - InvisionMag

(PRESS RELEASE) BELLEVILLE, NJ — Xenon-VR, Inc. of Belleville, New Jersey, USA, has officially changed its institution sanction to Xenon Ophthalmics Inc. Zeshan Khan, president, founder, and CEO of the company, states, “The caller sanction reflects our manufacture accent and expertise. It besides capitalizes connected our displacement distant from VR arsenic our superior offering to customers portion opening concern opportunities with different starring VR exertion companies to leverage our level and its patented proprietary medical-grade technology.”

Xenon Ophthalmics uses patented advancements successful Eye-Tracking Software, Artificial Intelligence, and Machine Learning, each integrated into a wearable medical-grade proprietary headset. In addition, the headset contains the company’s patented liquid lens technology, which tin beryllium tuned to acceptable each patient’s refractive error.

Recently, Xenon received patent approvals for exertion supporting ocular tract and autorefraction (objective and subjective refraction) functions, each combined successful a headset unit, allowing these tests to beryllium conducted rapidly and efficiently by the practitioner portion successful the bureau oregon portion moving remotely.

Unlike off-the-shelf headsets successful the oculus attraction marketplace, the Xenon portion is the archetypal purpose-built medical-grade exertion designed for the oculus practitioner successful mind, providing unlimited inherent diagnostic exams and gathering Goldmann perimetry standards.

For the eyecare professional, Xenon’s merchandise offering increases bureau efficiency, abstraction utilization, diligent comfort, and the broadest scope of tests compared to accepted ocular tract devices and earlier Virtual Reality (VR) units. As a result, ophthalmic and optometric professionals tin enactment faster and much efficiently, allowing expanded diligent attraction and enhanced revenue.

Xenon’s merchandise incorporates the diagnostic capabilities of accepted ophthalmic introspection devices specified arsenic phoropter, autorefractor, and ocular tract units.

Advertisement

In comparison, existent VR headsets lone supply screening exams specified arsenic ocular field, ocular acuity, and colour vision.

Xenon’s diagnostic technology, coupled with a precocious solution show that allows a ample tract of imaginativeness for users, enables functions of devices including car refractor and integer phoropters, each portion capturing Pupillary Distance (IPD).

Zeshan Khan continues, “We strive to acceptable a caller modular for each ophthalmic screening, diagnostic tests, and therapy successful the wearable aesculapian sector. Xenon Ophthalmics offers the lone headset successful the marketplace and successful the satellite that enables doctors to beryllium successful 2 locations simultaneously portion providing telehealth solutions to the oculus attraction sector.

Khan adds, “Our level allows oculus attraction professionals to analyse patients virtually portion performing imaging and lens adjustments successful existent time. Patients and doctors tin present beryllium successful 2 locations passim a broad oculus exam. Doctors tin usage our tablet to virtually power the headset and pass with patients conscionable arsenic if they were successful the aforesaid room. Our strategy volition alteration doctors to summation diligent volumes and ROI. It has been established unequivocally that tele-optometry services and easier entree to imaginativeness attraction makes people’s imaginativeness amended and improves their lives.”

Khan concludes, “Our full Xenon Ophthalmics squad is excited to bring a caller paradigm successful medical-grade, ophthalmic diagnostic exertion to the planetary oculus attraction marketplace.”